None of the 471 in the combination-therapy group developed tuberculosis vs 3 of 434 ( cumulative rate , 0.74 % ) in the isoniazid-only group , for a difference of -0.74 % and an upper bound of the 95 % CI of the difference of +0.32 % , which met the noninferiority criterion .